Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Repeated dose toxicity: dermal

Currently viewing:

Administrative data

Endpoint:
short-term repeated dose toxicity: dermal
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)

Data source

Reference
Reference Type:
publication
Title:
Final Report on the Safety Assessment of Sodium Picramate
Author:
Report by Sage publishers
Year:
1992
Bibliographic source:
JOURNAL OF THE AMERICAN COLLEGE OF TOXICOLOGY Volume 11, Number 4, Mary Ann Liebert, Inc., Publishers

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
other:
Principles of method if other than guideline:
The percutaneous toxicity of an oxidative hair dye formulation containing 0.1 % Sodium Picramate was evaluated using 12 (6 males, 6 females) adult New Zealand white rabbits. The hair dye was mixed with an equal volume of 6.0% hydrogen peroxide and applied (1 .O mI/kg) to the dorsolateral aspects of the thoracic-lumbar area twice per week for 13 weeks. Hair was clipped from application sites throughout the study. The application sites on six animals were abraded on the first day of each week of treatment. Application sites on all animals were shampooed, rinsed, and dried 1 h
after application of the dye.
GLP compliance:
not specified

Test material

Constituent 1
Reference substance name:
Sodium 2-amino-4,6-dinitrophenoxide
EC Number:
212-603-8
EC Name:
Sodium 2-amino-4,6-dinitrophenoxide
Cas Number:
831-52-7
IUPAC Name:
sodium 2-amino-4,6-dinitrophenolate

Test animals

Species:
rabbit
Strain:
New Zealand White
Sex:
male/female

Administration / exposure

Type of coverage:
open
Vehicle:
other: hydrogen peroxide
Duration of treatment / exposure:
13 weeks
Frequency of treatment:
twice per week
No. of animals per sex per dose:
6 males, 6 females
Control animals:
yes

Results and discussion

Results of examinations

Clinical signs:
no effects observed
Mortality:
no mortality observed
Haematological findings:
no effects observed
Clinical biochemistry findings:
no effects observed
Urinalysis findings:
no effects observed
Gross pathological findings:
no effects observed

Effect levels

Dose descriptor:
NOAEL
Effect level:
50 mg/kg bw/day
Based on:
test mat.
Sex:
male/female
Basis for effect level:
other: No adversed effects were observed (0.1% is equal to 50 mg/kg bw/day)

Target system / organ toxicity

Critical effects observed:
not specified

Applicant's summary and conclusion

Conclusions:
The no observed adversed effect level (NOEL) of Sodium picramate was observed at dose level of 0.1% ( i.e. 50 mg/kgbw/day) at this dose Neither gross nor microscopic changes related to administration of the dye were observed.
Executive summary:

The percutaneous toxicity of an oxidative hair dye formulation containing 0.1 % Sodium Picramate was evaluated using 12 (6 males, 6 females) adult New Zealand white rabbits. The hair dye was mixed with an equal volume of 6.0% hydrogen peroxide and applied (1 .O mI/kg) to the dorsolateral aspects of the thoracic-lumbar area twice per week for 13 weeks. Hair was clipped from application sites throughout the study. The application sites on six animals were abraded on the first day of each week of treatment. Application sites on all animals were shampooed, rinsed, and dried 1 h after application of the dye. Three groups of untreated rats (12 per group) served as controls. Analyses of blood and urine were done during weeks 0, 3, 7, and 13. Animals were sacrificed after week 13, and both gross and microscopic examinations performed. Slight thickening of the skin was observed only at sites where the dye had been

applied. There were statistically significant differences in clinical chemistry and hematological values between experimental and control groups. However, these differences were not considered to be of toxicological significance. The results of the urinalyses were unremarkable. thus we can conclude that the no observed adversed effect level (NOEL) of Sodium picramate was observed at dose level of 0.1% ( i.e. 50 mg/kgbw/day) at this dose Neither gross nor microscopic changes related to administration of the dye were observed.